stockrowFortrea Holdings Inc.
FTRE Healthcare Biotechnology
Fortrea Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 1.00% from fiscal 2024.
- Revenue
- −1.40%
- EPS
- +103.7%
- Free cash flow
- −34.0%
- Total debt
- −6.33%
Quarter to September 2026, against a year earlier
Follow FTRE
Alert me
Fortrea Holdings Inc. (FTRE) Price to free cash flow
As of 6 November 2026, Fortrea Holdings Inc. (FTRE) trades at a price to free cash flow of 12.3×. Over the past ten years it has ranged from 0.0× (December 2025) to 206× (June 2023); the current reading is higher than 67% of that period. That is below the Biotechnology industry median of 25.2× and below the Healthcare sector median of 20.5×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 17.8× | 153.83% |
| FY2024 | 7.0× | (68.67%) |
| FY2023 | 22.4× | (87.18%) |
| FY2022 | 175× | 0.00% |
| FY2021 | 175× | 0.00% |
| FY2020 | 175× | — |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Sep 2026 | 11.2× | 33.88% |
| Jun 2026 | 8.3× | 79.90% |
| Mar 2026 | 4.6× | (74.01%) |
| Dec 2025 | 17.8× | — |
| 13 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| BHVN Biohaven Ltd. compare | n/m |
| VIR Vir Biotechnology, Inc. compare | n/m |
| TRAX First Tracks Biotherapeutics, Inc. compare | n/m |
| REPL Replimune Group, Inc. compare | n/m |
| ZYME Zymeworks Inc. compare | n/m |
| IMNM Immunome, Inc. compare | n/m |
| HRMY Harmony Biosciences Holdings, Inc. compare | 6.8× |
| SRPT Sarepta Therapeutics, Inc. compare | 11.1× |
| FTRE Fortrea Holdings Inc. | 12.3× |
| Biotechnology industry median | 25.2× |
| Healthcare sector median | 20.5× |
| Market median | 14.0× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))